AIM IMMUNOTECH INC's ticker is AIM and the CUSIP is 00901B105. A total of 39 filers reported holding AIM IMMUNOTECH INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,933 | -32.8% | 85,566 | -1.1% | 0.00% | – |
| Q2 2023 | $57,966 | +55.8% | 86,517 | 0.0% | 0.00% | – |
| Q1 2023 | $37,202 | +37.9% | 86,517 | 0.0% | 0.00% | – |
| Q4 2022 | $26,985 | -46.0% | 86,517 | 0.0% | 0.00% | – |
| Q3 2022 | $50,000 | -27.5% | 86,517 | -2.5% | 0.00% | – |
| Q2 2022 | $69,000 | -26.6% | 88,707 | 0.0% | 0.00% | – |
| Q1 2022 | $94,000 | +14.6% | 88,707 | +0.1% | 0.00% | – |
| Q4 2021 | $82,000 | -54.2% | 88,662 | +0.3% | 0.00% | – |
| Q3 2021 | $179,000 | -4.8% | 88,416 | +1.4% | 0.00% | – |
| Q2 2021 | $188,000 | +22.1% | 87,226 | +28.8% | 0.00% | – |
| Q1 2021 | $154,000 | +33.9% | 67,746 | +5.4% | 0.00% | – |
| Q4 2020 | $115,000 | -17.9% | 64,303 | -1.5% | 0.00% | – |
| Q3 2020 | $140,000 | -2.1% | 65,267 | +13.4% | 0.00% | – |
| Q2 2020 | $143,000 | – | 57,566 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| XTX MARKETS LLC | 11,019 | $20,000 | 0.04% |
| Virtu Financial LLC | 103,807 | $186,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 10,000 | $18,000 | 0.01% |
| SeaCrest Wealth Management, LLC | 48,873 | $87,000 | 0.01% |
| Arkadios Wealth Advisors | 20,000 | $35,000 | 0.01% |
| Traynor Capital Management, Inc. | 14,777 | $26,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 17,047 | $31,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 111,000 | $199,000 | 0.00% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 20,200 | $36,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 12,513 | $22,000 | 0.00% |